CARBOXAMIDE COMPOUNDS AND USE THEREOF AS CALPAIN INHIBITORS Russian patent published in 2013 - IPC C07D401/04 C07D401/14 C07D409/14 A61K31/4439 A61P25/00 

Abstract RU 2485114 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to new carboxamide compounds of formula I-A' or I-A" , as well as to tautomers thereof and pharmaceutically acceptable salts thereof, wherein R1 means hydrogen, C1-C10-alkyl, C3-C7-cycloalkyl-C1-C4alkyl, aryl-C1-C6-alkyl or hetaryl-C1-C4-alkyl, wherein aryl and hetaryl in the two last mentioned radicals may be substituted or have 1 radical R1c; wherein R1a represents C1-C6-alkoxy, R1c is independently specified in halogen, CN, CF3, O-CF3, O-CHF2, C1-C6-alkyl, C1-C6-alkoxy, hetaryl, O-CH2-aryl, - (CH2)p-NRc6Rc7 with p = 0 or 1; wherein Rc6 represents C1-C6-alkyl or SO2-C1-C6-alkyl, and Rc7 represents C1-C6-alkyl, or the two radicals Rc6 and Rc7 together with an N atom form 5- or 6-member, optionally substituted C1-C4-alkyl nitrogen-containing heterocyclyl which can optionally have 1 heteroatom from the group O and N as ring members, R2 means C1-C10-alkyl, C3-C7-cycloalkyl, aryl, hetaryl, wherein aryl and hetaryl in the two last mentioned radicals may be unsubstituted or carry 1, 2 or 3 identical or different R2c radicals; wherein R2c have one of the values specified for R1c; R3a and R3b together with a carbon atom whereto attached, are C=O; X means hydrogen or a radical of formulas C(=O)-O-Rx1 or C(=O)-NRx2Rx3, wherein Rx1 means C1-C6-alkyl, Rx2 means H or C1-C6-alkyl, and Rx2 means H, one of the variables Y1, Y2, Y3 and Y4 forms a nitrogen atom, and the rest variables Y1, Y2, Y3 and Y4 mean CH, n is equal to 0 or 1, Ry is independently specified in halogen, CN, aryl, -NH-SO2-Ry4, -(CH2)p-NRy6Ry7 with p = 0; wherein Ry4 means C1-C6-alkyl, Ry6 has one of the values specified for Rc6, and Ry7 has one of the values specified for Rc7; m means 0 or 1 for formulas I-A', and Rw is specified in halogen, C1-C6-alkyl, C1-C6-alkoxy, wherein C1-C6-alkyl can have 1 substitute Rwa, aryl, -(CH2)p-NRw6Rw7 with p = 0 or 1, Rwa has one of the values specified for R1a, or represents NRa2SO2Ra4, Ra2 represents H, Ra4 represents C1-C6-alkyl, Rw6 has one of the values specified for Rc6, Rw7 has one of the values specified for Rc7, m is equal to 0, 1 or 2 for formula I-A", and Rw6* has one of the values specified for Rw, E has one of the values specified for: -CHRE2-CHRE3-, -CH2-O-, -O-CH2-, -S-CH2-, -CH2-S-, -CH2-SO2-, -SO2-CH2-, wherein Re2, Re3 represent hydrogen; wherein aryls defined above, represent mono- or bicyclic aromatic hydrocarbon radicals such as phenyl or naphthyl, and hetaryls defined above, represent 5 - or 6-member aromatic heterocyclic radicals containing 1 or 2 heteroatoms specified in nitrogen, oxygen and sulphur and can additionally contain a condensed benzene ring. Also, the invention refers to specific compounds, pharmaceutical compositions containing them and use thereof.

EFFECT: there are prepared new derivatives of carboxamide compounds effective in the treating the disorders caused by higher activity of calpain.

15 cl, 1 tbl, 195 ex

Similar patents RU2485114C2

Title Year Author Number
CARBOXAMIDE COMPOUNDS AND USE THEREOF AS CALPAIN INHIBITORS 2010
  • Kling Andreas
  • Jantos Katja
  • Mak Khel'Mut
  • Meller Akhim
  • Khornberger Vil'Frid
  • Bakfish Gizela
  • Lao Jan'Bin'
  • Nejsen Mar'Olen
RU2567392C2
CARBOXAMIDE COMPOUNDS AND USING THEM AS CALPAIN INHIBITORS 2010
  • Mak Khel'Mut
  • Kling Andreas
  • Jantos Katja
  • Meller Akhim
  • Khornberger Vil'Frid
  • Khatchins Charl'Z V.
RU2540856C2
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS 2009
  • Pazh Patrik
  • Ochard Majk
  • Lale Benua
  • Gadzhini Francheska
RU2538041C2
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS 2009
  • Pazh Patrik
  • Ochard Majk
  • Lale Benua
  • Gadzhini Francheska
RU2532161C2
PYRAZOLO[3,4-b]PURIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION (VERSIONS), APPLICATION (VERSIONS), COMBINATION (VERSIONS) 2003
  • Allen Dejvid Dzhordzh
  • Kou Dajan Mehri
  • Kuk Kehrolin Mehri
  • Doul Majkl Dehnnis
  • Ehdlin Kristofer Dejvid
  • Khehmblin Dzhuli Nikol'
  • Dzhonson Martin Redpat
  • Dzhounz Pol Spenser
  • Noulz Richard Grehm
  • Mitchell Sharlott Dzhejn
  • Redgrejv Ehlison Dzhudit
  • Uord Piter
  • Lindvall Mika Kristian
RU2357967C2
PYRROLO- AND THIAZOLOPYRIDINE COMPOUNDS (VERSIONS) AND BASED PHARMACEUTICAL COMPOSITION 2007
  • Arend Majkl P.
  • Vu Min'
  • Dehn Shaotszjan
  • Tertl Ehrik D.
  • Flippin Li Eh.
  • Kho Vehn'-Bin'
  • Chehn Khehn
RU2461557C2
PYRAZOLE PYRIDINE DERIVATIVES AS NADPH-OXIDASE 2009
  • Pazh Patrik
  • Ochard Majk
  • Lale Benua
  • Gadzhini Francheska
RU2548022C2
CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS 2010
  • Kristin Brazerton-Plejss
  • Ralf N'Ju Kharris Iii
  • Brehdli Eh. Lo
  • Fransisko-Khav'Er Lopes-Tapija
  • Pankadzh D. Rege
  • Dejvid Brjus Repke
  • Rassel Stiven Stabler
  • Kejt Adrian Marri Uolker
RU2533122C2
PHARMACEUTICAL COMPOSITION CONTAINING BENZODIAZEPINE DERIVATIVES AND RSV FUSION PROTEIN INHIBITOR 2005
  • Pauehll Kennet
  • Kelsi Richard
  • Karter Malkolm
  • Alber Dagmar
  • Uilson Lara
  • Khenderson Ehlajsa
  • Chambers Fil
  • Tejlor Debra
  • Tims Stehn
  • Daudell Veriti
RU2388476C2
METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS 2012
  • Gallakher Mikhela
  • Khaberman Rebekka
  • Kokh Min Ten
RU2665021C2

RU 2 485 114 C2

Authors

Kling Andreas

Khornberger Vil'Frid

Mak Khel'Mut

Meller Akhim

Nimmrikh Fol'Ker

Zeemann Ditmar

Lubish Vil'Frid

Dates

2013-06-20Published

2007-12-28Filed